Suicide risk and efficacy of antidepressant drugs--reply.
暂无分享,去创建一个
J. Mann | R. Gibbons | K. Hur | C. Brown | J. Davis
[1] J. Mann,et al. Benefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine. , 2012, Archives of general psychiatry.
[2] J. Mann,et al. Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine. , 2012, Archives of general psychiatry.
[3] P. Rohde,et al. Suicidal events in the Treatment for Adolescents With Depression Study (TADS). , 2009, The Journal of clinical psychiatry.
[4] M. Oquendo,et al. Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. , 2007, The American journal of psychiatry.
[5] J. Biederman,et al. Atomoxetine alone or combined with fluoxetine for treating ADHD with comorbid depressive or anxiety symptoms. , 2005, Journal of the American Academy of Child and Adolescent Psychiatry.
[6] M. Hamilton. A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.